201 – 210 of 262
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Immunomodulation by fluoroquinolones and other antibacterial agents.
(
- Contribution to journal › Letter
-
Mark
The IgD C(H)1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID.
(
- Contribution to journal › Article
-
Mark
The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines.
(
- Contribution to journal › Article
- 2005
-
Mark
The Respiratory Pathogen Moraxella catarrhalis Adheres to Epithelial Cells by Interacting with Fibronectin through Ubiquitous Surface Proteins A1 and A2.
(
- Contribution to journal › Article
-
Mark
Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity
(
- Contribution to journal › Article
-
Mark
A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells.
(
- Contribution to journal › Article
-
Mark
The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children.
(
- Contribution to journal › Article
- 2004
-
Mark
The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2
(
- Contribution to journal › Article
-
Mark
Immunization with the Truncated Adhesin Moraxella catarrhalis Immunoglobulin D-Binding Protein (MID764-913) Is Protective against M. catarrhalis in a Mouse Model of Pulmonary Clearance.
(
- Contribution to journal › Article
-
Mark
Septicemia with Staphylococcus aureus, beta-hemolytic streptococei group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra)
(
- Contribution to journal › Letter